Form SCHEDULE 13G/A Centessa Pharmaceuticals Filed by: Avoro Capital Advisors LLC
Centessa Pharmaceuticals plc - American Depositary Shares (CNTA)
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
CNTA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CNTA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CNTA alerts
High impacting Centessa Pharmaceuticals plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
CNTA
News
- Are CNTA, KORE, CWAN Obtaining Fair Deals for their Shareholders?PR Newswire
- Centessa Pharmaceuticals (CNTA) had its "equal weight" rating reaffirmed by Wells Fargo & Company. They now have a $42.00 price target on the stock, up from $35.00.MarketBeat
- Centessa Pharmaceuticals (CNTA) was downgraded by Truist Financial Corporation from "buy" to "hold". They now have a $38.00 price target on the stock.MarketBeat
- Shareholder Alert: The Ademi Firm investigates whether Centessa Pharmaceuticals plc is obtaining a Fair Price for Public ShareholdersGlobeNewswire
- Centessa Pharmaceuticals (CNTA) had its "neutral" rating reaffirmed by Guggenheim.MarketBeat
CNTA
Earnings
- 3/31/26 - Miss
CNTA
Sec Filings
- 4/17/26 - Form PREM14A
- 4/13/26 - Form DEFA14A
- 3/31/26 - Form DEFA14A
- CNTA's page on the SEC website